提议的剂量和疗程的 thiazide 利尿剂在预防复发性尿病:一个 upstate 的元分析
Li Yi1,2, Hui Wang1,3, Yu Ji1,2
1Department of Urology, Qilu Hospital of Shandong University, Wenhuaxi Road 107#, Jinan, Shandong Province, 250012, PR China.
World journal of urology
|February 17, 2025
概括
铁化尿剂有效地预防了复发性尿病. 最佳的治疗方法是每天服用50毫克甲酸,持续36个月,以预防结石.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 有关 thiazide 利尿剂在预防复发性尿病的有效性存在争议的结果.
- 目前的指导方针缺乏关于最佳剂量和时间的具体建议,以治疗 thiazide 利尿剂.
- 需要进行元分析,以澄清 thiazide 利尿剂在治疗复发性结石中的作用.
研究的目的:
- 评估 thiazide 利尿剂在预防复发性尿病的疗效.
- 确定用于预防结石的 thiazide 利尿剂的最佳剂量.
- 为了确定尿病患者的 thiazide 利尿剂治疗的理想治疗持续时间.
主要方法:
- 在PubMed,Embase和Cochrane图书馆进行了全面的文献搜索,截至2024年1月.
- 符合条件的研究进行了元分析和子组分析,以评估疗效,剂量和持续时间.
- 出版偏差是使用埃格尔的测试来评估的.
主要成果:
- 包括1217名患者在内的12项研究表明, thiazide利尿剂显著降低了复发性尿病风险 (RR=0.55).
- 每日50毫克的化物胺剂量证明了统计学上的有效性.
- 治疗时间为24-36个月被证明是有效的,其中36个月的甲酸显示出显著的益处.
结论:
- 铁酸性利尿剂在预防复发性尿病时有效.
- 最佳治疗方案是每天服用50毫克的化物,持续36个月.
- 这种剂量和持续时间为易患结石的患者提供了明确的指导方针.
相关概念视频
Drug Elimination by Renal Route: Tubular Reabsorption
3.1K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.1K
Dosage Regimen: Fixed Dose
1.8K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.8K
Antihypertensive Drugs: Action of Diuretics
613
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
613
Antihypertensive Drugs: Thiazide-Class Diuretics
522
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
522
Antihypertensive Drugs: Potassium-Sparing Diuretics
439
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
439
Renal Failure: Dose Adjustments
60
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
60
